Interest Expense in USD of AGILE THERAPEUTICS INC from 2012 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Agile Therapeutics Inc quarterly/annual Interest Expense history and change rate from 2012 to Q1 2024.
  • Agile Therapeutics Inc Interest Expense for the quarter ending 31 Mar 2024 was $185K, a 54% decline year-over-year.
  • Agile Therapeutics Inc Interest Expense for the twelve months ending 31 Mar 2024 was $1.2M, a 54.8% decline year-over-year.
  • Agile Therapeutics Inc annual Interest Expense for 2023 was $1.42M, a 54.7% decline from 2022.
  • Agile Therapeutics Inc annual Interest Expense for 2022 was $3.13M, a 20% decline from 2021.
  • Agile Therapeutics Inc annual Interest Expense for 2021 was $3.91M, a 25.9% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)

AGILE THERAPEUTICS INC Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.2M $185K -$217K -54% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2024
Q4 2023 $1.42M $304K -$128K -29.6% 01 Oct 2023 31 Dec 2023 10-K 28 Mar 2024
Q3 2023 $1.55M $341K -$663K -66% 01 Jul 2023 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 $2.21M $372K -$451K -54.8% 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024
Q1 2023 $2.66M $402K -$470K -53.9% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024
Q4 2022 $3.13M $432K -$568K -56.8% 01 Oct 2022 31 Dec 2022 10-K 28 Mar 2024
Q3 2022 $3.7M $1M +$5K +0.5% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 $3.69M $823K -$170K -17.1% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023
Q1 2022 $3.86M $872K -$50K -5.42% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 $3.91M $1M +$96K +10.6% 01 Oct 2021 31 Dec 2021 10-K 28 Mar 2024
Q3 2021 $3.82M $999K +$94K +10.4% 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022
Q2 2021 $3.72M $993K +$91K +10.1% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022
Q1 2021 $3.63M $922K +$524K +132% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q4 2020 $3.11M $904K 01 Oct 2020 31 Dec 2020 10-K 23 Mar 2023
Q3 2020 $905K 01 Jul 2020 30 Sep 2020 10-Q/A 30 Dec 2021
Q2 2020 $902K 01 Apr 2020 30 Jun 2020 10-Q 26 Jul 2021
Q1 2020 $398K 01 Jan 2020 31 Mar 2020 10-Q 04 May 2021
Q4 2018 $1.12M $160K -$249K -60.9% 01 Oct 2018 31 Dec 2018 10-K 01 Mar 2021
Q3 2018 $1.37M $268K -$191K -41.6% 01 Jul 2018 30 Sep 2018 10-Q 28 Oct 2019
Q2 2018 $1.56M $320K -$184K -36.5% 01 Apr 2018 30 Jun 2018 10-Q 01 Aug 2019
Q1 2018 $1.74M $368K -$178K -32.6% 01 Jan 2018 31 Mar 2018 10-Q 03 May 2019
Q4 2017 $1.92M $409K -$157K -27.7% 01 Oct 2017 31 Dec 2017 10-K 20 Feb 2020
Q3 2017 $2.08M $459K -$325K -41.5% 01 Jul 2017 30 Sep 2017 10-Q 02 Nov 2018
Q2 2017 $2.4M $504K -$44K -8.03% 01 Apr 2017 30 Jun 2017 10-Q 03 Aug 2018
Q1 2017 $2.44M $546K -$2K -0.37% 01 Jan 2017 31 Mar 2017 10-Q 07 May 2018
Q4 2016 $2.45M $566K +$12K +2.17% 01 Oct 2016 31 Dec 2016 10-K 12 Mar 2019
Q3 2016 $2.43M $784K +$233K +42.3% 01 Jul 2016 30 Sep 2016 10-Q 06 Nov 2017
Q2 2016 $2.2M $548K +$1K +0.18% 01 Apr 2016 30 Jun 2016 10-Q 28 Jul 2017
Q1 2016 $2.2M $548K +$123K +28.9% 01 Jan 2016 31 Mar 2016 10-Q 08 May 2017
Q4 2015 $2.08M $554K +$162K +41.2% 01 Oct 2015 31 Dec 2015 10-K 12 Mar 2018
Q3 2015 $1.92M $551K +$159K +40.6% 01 Jul 2015 30 Sep 2015 10-Q 07 Nov 2016
Q2 2015 $1.76M $547K +$144K +35.6% 01 Apr 2015 30 Jun 2015 10-Q 08 Aug 2016
Q1 2015 $1.61M $425K +$46.8K +12.4% 01 Jan 2015 31 Mar 2015 10-Q 09 May 2016
Q4 2014 $1.57M $392K 01 Oct 2014 31 Dec 2014 10-K 15 Mar 2017
Q3 2014 $392K +$13.8K +3.64% 01 Jul 2014 30 Sep 2014 10-Q 09 Nov 2015
Q2 2014 $403K +$25.3K +6.68% 01 Apr 2014 30 Jun 2014 10-Q 13 Aug 2015
Q1 2014 $378K 01 Jan 2014 31 Mar 2014 10-Q 12 May 2015
Q3 2013 $378K 01 Jul 2013 30 Sep 2013 10-Q 13 Nov 2014
Q2 2013 $378K 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014

AGILE THERAPEUTICS INC Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.42M -$1.71M -54.7% 01 Jan 2023 31 Dec 2023 10-K 28 Mar 2024
2022 $3.13M -$783K -20% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024
2021 $3.91M +$805K +25.9% 01 Jan 2021 31 Dec 2021 10-K 28 Mar 2024
2020 $3.11M 01 Jan 2020 31 Dec 2020 10-K 23 Mar 2023
2018 $1.12M -$802K -41.8% 01 Jan 2018 31 Dec 2018 10-K 01 Mar 2021
2017 $1.92M -$528K -21.6% 01 Jan 2017 31 Dec 2017 10-K 20 Feb 2020
2016 $2.45M +$369K +17.8% 01 Jan 2016 31 Dec 2016 10-K 12 Mar 2019
2015 $2.08M +$511K +32.6% 01 Jan 2015 31 Dec 2015 10-K 12 Mar 2018
2014 $1.57M +$53K +3.5% 01 Jan 2014 31 Dec 2014 10-K 15 Mar 2017
2013 $1.51M +$1.37M +980% 01 Jan 2013 31 Dec 2013 10-K 09 Mar 2016
2012 $140K 01 Jan 2012 31 Dec 2012 10-K 26 Mar 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.